• Action Plan to Capture Future Medicines Manufacturing Jobs

    News

    Action Plan to Capture Future Medicines Manufacturing Jobs

    During the Annual bioprocess UK conference in Newcastle, (23 November 2016), the Advanced Therapies Manufacturing Taskforce (ATMT), published its new strategy outlining how the UK can become the global hub of advanced medicinal therapy manufacturing and ensure the long-term success of this industry in the UK.

    Advanced Therapies Manufacturing Action Plan, retaining and attracting advanced therapies manufacture in the UK’, looks at the medicines manufacturing industry of the future which is expected to grow to be worth between $14-21bn globally per year by 2025.

    The taskforce is co-chaired by Minister of State for Universities, Science, Research and Innovation, Jo Johnson MP and Ian McCubbin, SVP North America, Japan & Global Pharma Supply, GlaxoSmithKline. There is an ongoing dialogue between the sector and the government on the pivotal role the life sciences sector has to play in the UK’s overarching Industrial Strategy.                              

    Jo Johnson MP, said: “The report comes at an opportune time with development of the Government’s Industrial Strategy. This is a critical part of the Prime Minister’s ambition to build an economy that works for everyone.  The strategy will set out how we will boost productivity, create good jobs, and ensure sustainable economic growth. Life Sciences and within that, Advanced Therapies – hold great potential for the UK to develop new sources of economic competitiveness. The report provides a valuable input as we develop the Industrial Strategy.  I welcome continued commitment and engagement from your industry.”

    Ian McCubbin, added: "The life sciences have always been strong in the UK and as the Government sets out its forthcoming Industrial Strategy, we recommend that it proactively targets future areas of growth – advanced therapies manufacturing being one of these areas. The UK needs to act with urgency and differentiate itself as a global destination for advanced therapies development and manufacturing and set the sustainable foundations for this emergent sector to take root and grow"


    Digital Edition

    ILM 50.2 March 2025

    March 2025

    Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...

    View all digital editions

    Events

    Bio-Europe Spring

    Mar 17 2025 Milan, Italy

    NGVS 2025

    Mar 18 2025 Beijing, China

    Laborama 2025

    Mar 20 2025 Brussels, Belgium

    Asia Labex

    Mar 20 2025 Chandigarh, India

    ACS National Meeting & Expo, Spring 2025

    Mar 23 2025 San Diego, CA, USA

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Labmate for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Laboratory products, news and services. Join us and get the latest Laboratory information first.